Related Experiment Video

Updated: Sep 26, 2026

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models
07:49

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models

Published on: July 21, 2023

[Treatment for diastolic failure]

Koichiro Kinugawa1, Toshiyuki Takahashi, Ryozo Nagai

  • 1Department of Cardiovascular Medicine, University of Tokyo.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|May 21, 2003
PubMed

Insights

Diastolic dysfunction, a key heart failure mechanism, lacks established treatments. Angiotensin II blockade shows promise for treating diastolic failure by targeting myocardial hypertrophy and fibrosis.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Pharmacology

Background:

  • Diastolic dysfunction is a significant contributor to heart failure.
  • Myocardial hypertrophy and fibrosis are primary causes of diastolic dysfunction.
  • Angiotensin II is implicated as a key growth factor in cardiac remodeling.

Purpose of the Study:

  • To review the pathophysiologic basis of diastolic dysfunction.
  • To discuss potential treatments for diastolic failure.
  • To explore the role of Angiotensin II blockade in managing diastolic dysfunction.

Main Methods:

  • Literature review of pathophysiologic mechanisms.
  • Analysis of current research on diastolic dysfunction causes.
  • Examination of therapeutic strategies targeting Angiotensin II.

Main Results:

  • Angiotensin II is identified as a critical factor in myocardial hypertrophy and fibrosis.
  • Angiotensin II blockade emerges as a promising therapeutic approach.
  • Ongoing randomized studies are evaluating Angiotensin II type 1 receptor blockers.

Conclusions:

  • Understanding diastolic dysfunction's pathophysiology is crucial for treatment development.
  • Targeting Angiotensin II pathways offers a potential strategy for diastolic failure.
  • Further clinical trials are needed to establish effective treatments for diastolic dysfunction.

More Related Videos

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease08:57

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease

Published on: May 22, 2026

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...